Delavirdine contraindications: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 5: | Line 5: | ||
==Contraindications== | ==Contraindications== | ||
RESCRIPTOR Tablets are contraindicated in patients with known hypersensitivity to any of its ingredients. Coadministration of RESCRIPTOR is contraindicated with drugs that are highly dependent on | RESCRIPTOR Tablets are contraindicated in patients with known [[hypersensitivity]] to any of its ingredients. Coadministration of RESCRIPTOR is contraindicated with drugs that are highly dependent on [[CYP]]3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events. These drugs are listed in Table 5. Also, see PRECAUTIONS, Table 6, Drugs That Should Not Be Coadministered With RESCRIPTOR.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = RESCRIPTOR (DELAVIRDINE MESYLATE) TABLET [VIIV HEALTHCARE COMPANY] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eb28dcd2-c457-4137-9eec-00062e5a601b | publisher = | date = | accessdate = }}</ref> | ||
{| | {| | ||
|[[File:Delcontra.JPG|800px|thumb]] | |[[File:Delcontra.JPG|800px|thumb]] | ||
|} | |} | ||
Latest revision as of 03:49, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Contraindications
RESCRIPTOR Tablets are contraindicated in patients with known hypersensitivity to any of its ingredients. Coadministration of RESCRIPTOR is contraindicated with drugs that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events. These drugs are listed in Table 5. Also, see PRECAUTIONS, Table 6, Drugs That Should Not Be Coadministered With RESCRIPTOR.[1]
 |
References
Adapted from the FDA Package Insert.